1. Home
  2. Labeler Index
  3. Pfizer Laboratories Div Pfizer Inc
  4. 60793-602
  5. NDC Package Code: 60793-602-10 Bicillin C-r 900/300

NDC Package 60793-602-10 Bicillin C-r 900/300

Penicillin G Benzathine And Penicillin G Procaine Injection, Suspension Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
60793-602-10
Package Description:
10 SYRINGE in 1 PACKAGE / 2 mL in 1 SYRINGE (60793-602-02)
Product Code:
60793-602
Proprietary Name:
Bicillin C-r 900/300
Non-Proprietary Name:
Penicillin G Benzathine And Penicillin G Procaine
Substance Name:
Penicillin G Benzathine; Penicillin G Procaine
Usage Information:
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R 900/300 and other antibacterial drugs, Bicillin C-R 900/300 should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Bicillin C-R 900/300 is indicated in the treatment of infections as described below that are susceptible to serum levels characteristic of this particular dosage form. Therapy should be guided by bacteriological studies (including susceptibility testing) and by clinical response. Bicillin C-R 900/300 is indicated in the treatment of the following in pediatric patients: Moderately severe to severe infections of the upper-respiratory tract, scarlet fever, erysipelas, and skin and soft-tissue infections due to susceptible streptococci. NOTE: Streptococci in Groups A, C, G, H, L, and M are very susceptible to penicillin G. Other groups, including Group D (enterococci), are resistant. Penicillin G sodium or potassium is recommended for streptococcal infections with bacteremia. Moderately severe pneumonia and otitis media due to susceptible Streptococcus pneumoniae. NOTE: Severe pneumonia, empyema, bacteremia, pericarditis, meningitis, peritonitis, and arthritis of pneumococcal etiology are better treated with penicillin G sodium or potassium during the acute stage. When high, sustained serum levels are required, penicillin G sodium or potassium, either IM or IV, should be used. This drug should not be used in the treatment of venereal diseases, including syphilis, gonorrhea, yaws, bejel, and pinta.
11-Digit NDC Billing Format:
60793060210
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 836306 - penicillin G benzathine / penicillin G procaine 1,200,000 UNT (900,000 UNT/ 300,000 UNT) in 2 ML Prefilled Syringe
  • RxCUI: 836306 - 2 ML penicillin G benzathine 450000 UNT/ML / penicillin G procaine 150000 UNT/ML Prefilled Syringe
  • RxCUI: 836306 - penicillin G benzathine 900,000 UNT / penicillin G procaine 300,000 UNT per 2 ML Prefilled Syringe
  • RxCUI: 836307 - BICILLIN C-R 900/300 1,200,000 UNT in 2 ML Prefilled Syringe
  • RxCUI: 836307 - 2 ML penicillin G benzathine 450000 UNT/ML / penicillin G procaine 150000 UNT/ML Prefilled Syringe [Bicillin]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Dosage Form:
    Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
    Administration Route(s):
  • Intramuscular - Administration within a muscle.
    • Active Ingredient(s):
  • PENICILLIN G BENZATHINE 900000 [iU]/2mL
  • PENICILLIN G PROCAINE 300000 [iU]/2mL
    • Pharmacologic Class(es):
  • Penicillin-class Antibacterial - [EPC] (Established Pharmacologic Class)
  • Penicillin-class Antibacterial - [EPC] (Established Pharmacologic Class)
  • Penicillins - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA050138
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    05-18-1953
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 60793-602-10 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    60793060210J0558Peng benzathine/procaine inj100,000 UNITS21012120

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 60793-602-10?

    The NDC Packaged Code 60793-602-10 is assigned to a package of 10 syringe in 1 package / 2 ml in 1 syringe (60793-602-02) of Bicillin C-r 900/300, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is injection, suspension and is administered via intramuscular form.

    Is NDC 60793-602 included in the NDC Directory?

    Yes, Bicillin C-r 900/300 with product code 60793-602 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on May 18, 1953 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 60793-602-10?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 60793-602-10?

    The 11-digit format is 60793060210. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-260793-602-105-4-260793-0602-10